Our identification of TP53, MAPKAPK5, and HLA-G as MAMs-related biomarkers provides novel insights into how MAM dysfunction contributes to AF pathogenesis, particularly the intersection of MAM dysfunction, immune dysregulation, and atrial remodeling. The gene discussed is HLA-G; the disease is atrial fibrillation.